An observational study in Aggressive Periodontitis, sponsored by Future University in Egypt. Completed at 1 site in Egypt. Open to participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-25.
Sponsored by Future University in Egypt · Observational
The current study was performed to study levels of Il-17 and Il-18 in aggressive periodontitis patients before and after non surgical periodontal therapy
Background:host defense factors are involved in pathogenesis of chronic periodontitis so, the current study is assessing levels of Il-17 and Il-18 in chronic periodontitis patients versus periodontally healthy controls.
Subjects and methods: Fifty subjects were included; twenty five of them are diagnosed with chronic periodontitis patients and twenty five are periodontally healthy subjects. Probing depth (PD), clinical attachment level (CAL), plaque index (PI) and gingival index (GI) were recorded for all the enrolled subjects. GCF levels of Il-17 and IL-18 were analyzed by enzyme-linked immunosorbent assay (ELISA).
1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.
This study's enrollment of 50 is below the median of 90 across 428 observational studies indexed under Periodontitis.
Browse Periodontitis studies →Future University in Egypt is the lead sponsor of 97 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Chronic periodontitis patients
Exclusion Criteria:
scaling and root planing
Procedure: non surgical periodontal therapy
no treatment
Scaling and root planing
measure levels of Il-17 and Il-18 in chronic periodontitis patients
measure levels of Il-17 and Il-18 in GCF of chronic periodontitis patients
Time frame: Change from Baseline Il-17 andIl-18 at 3 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Future University in Egypt